BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25824311)

  • 1. Frontline therapy of severe aplastic anaemia with fludarabine, cyclophosphamide and ciclosporin.
    Liu Q; Zhao X; Xu N; Huang P; Li S; Zhang F; Wang J
    Br J Haematol; 2015 Nov; 171(3):427-30. PubMed ID: 25824311
    [No Abstract]   [Full Text] [Related]  

  • 2. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
    Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
    Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cyclophosphamide in aplastic anaemia.
    Brodsky RA; Jones RJ
    Lancet; 2001 Apr; 357(9262):1128-9. PubMed ID: 11303606
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
    Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
    Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.
    Koh KN; Im HJ; Kim BE; Choi ES; Jang S; Kwon SW; Park CJ; Seo JJ
    Br J Haematol; 2012 Apr; 157(1):139-42. PubMed ID: 22055111
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.
    Bacigalupo A; Locatelli F; Lanino E; Marsh J; Socié G; Maury S; Prete A; Locasciulli A; Cesaro S; Passweg J;
    Bone Marrow Transplant; 2005 Dec; 36(11):947-50. PubMed ID: 16205733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.
    Kohashi S; Mori T; Hashida R; Kato J; Saburi M; Kikuchi T; Koda Y; Toyama T; Yamane Y; Yamanaka S; Okamoto S
    Int J Hematol; 2015 Jan; 101(1):102-5. PubMed ID: 25381590
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
    Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M
    Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.
    Song Y; Li N; Liu Y; Fang B
    Br J Haematol; 2013 Jan; 160(2):266-9. PubMed ID: 23116478
    [No Abstract]   [Full Text] [Related]  

  • 10. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia.
    Leeksma OC; Thomas LL; van der Lelie J; van Oers MH; von dem Borne AE; Goudsmit R
    Neth J Med; 1992 Oct; 41(3-4):143-8. PubMed ID: 1470285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia.
    Shao Y; Li X; Shi J; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
    Br J Haematol; 2013 Aug; 162(4):552-5. PubMed ID: 23700976
    [No Abstract]   [Full Text] [Related]  

  • 13. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
    Tisdale JF; Dunn DE; Geller N; Plante M; Nunez O; Dunbar CE; Barrett AJ; Walsh TJ; Rosenfeld SJ; Young NS
    Lancet; 2000 Nov; 356(9241):1554-9. PubMed ID: 11075769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
    Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen.
    Wang SB; Li L; Pan XH; Hu DM; Peng LH; Liu L; Xie ZJ; Yin B; Sun XJ; Yu J; Liang Y
    Clin Transplant; 2013; 27(2):E109-15. PubMed ID: 23387380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers.
    George B; Mathews V; Lakshmi KM; Melinkeri S; Sharma A; Viswabandya A; Sharma S; Das S; Ahmed R; Abraham A; Nair V; Apte S; Chandy M; Srivastava A
    Clin Transplant; 2013; 27(6):923-9. PubMed ID: 24304374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.
    Kim H; Lee KH; Kim I; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Oh S; Kim HJ; Park JH;
    Leuk Res; 2014 Jul; 38(7):730-6. PubMed ID: 24840870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
    Ambulkar I; Parikh PM; Saikia T
    J Assoc Physicians India; 2003 Jul; 51():715-6. PubMed ID: 14621044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.